home / stock / tdsgf / tdsgf quote
Last: | $0.1035 |
---|---|
Change Percent: | 0.0% |
Open: | $0.1035 |
Close: | $0.1035 |
High: | $0.1035 |
Low: | $0.1035 |
Volume: | 300 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1035 | $0.1035 | $0.1035 | $0.1035 | $0.1035 | 300 | 07-19-2024 |
$0.14565 | $0.1295 | $0.14565 | $0.14565 | $0.1295 | 8,840 | 07-17-2024 |
$0.136 | $0.1348 | $0.136 | $0.136 | $0.1348 | 16,000 | 07-15-2024 |
$0.1348 | $0.1199 | $0.1348 | $0.1348 | $0.1199 | 7,750 | 07-10-2024 |
$0.13485 | $0.13485 | $0.13485 | $0.13485 | $0.13485 | 10,000 | 07-09-2024 |
$0.1417 | $0.1417 | $0.1417 | $0.1417 | $0.1417 | 500 | 07-08-2024 |
$0.1226 | $0.1226 | $0.1226 | $0.1226 | $0.1226 | 2,000 | 07-05-2024 |
$0.13885 | $0 | $0.13885 | $0 | $0 | 80 | 07-03-2024 |
$0.13885 | $0.15754 | $0.13885 | $0.15754 | $0.13885 | 1,260 | 07-02-2024 |
$0.164 | $0.164 | $0.164 | $0.164 | $0.164 | 120 | 07-01-2024 |
$0.15765 | $0.1332 | $0.15765 | $0.15765 | $0.1332 | 600 | 06-27-2024 |
$0.15155 | $0.1053 | $0.15155 | $0.15155 | $0.1053 | 17,325 | 06-26-2024 |
$0.1685 | $0.1685 | $0.1685 | $0.1685 | $0.1685 | 17,225 | 06-25-2024 |
$0.1555 | $0.1555 | $0.1555 | $0.1555 | $0.1555 | 100 | 06-24-2024 |
$0.1437 | $0.1793 | $0.1437 | $0.1793 | $0.1437 | 205,975 | 06-21-2024 |
$0.1548 | $0.1548 | $0.1548 | $0.1548 | $0.1548 | 100 | 06-19-2024 |
$0.1548 | $0.1548 | $0.1548 | $0.1548 | $0.1548 | 100 | 06-18-2024 |
$0.1428 | $0.1369 | $0.1428 | $0.1428 | $0.1369 | 1,043 | 06-17-2024 |
$0.15 | $0.1439 | $0.15 | $0.15 | $0.1439 | 4,400 | 06-14-2024 |
$0.152 | $0.1417 | $0.152 | $0.152 | $0.1417 | 200 | 06-12-2024 |
News, Short Squeeze, Breakout and More Instantly...
Teledata Singapore Ltd Company Name:
TDSGF Stock Symbol:
OTCMKTS Market:
Teledata Singapore Ltd Website:
Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncolo...
Toronto, Ontario--(Newsfile Corp. - June 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ("Telo" or the "Company"), is pleased to announce that results of the development, validation and implementation of its machine learning and Artificial Intelligence (AI) modules, u...
Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), ( the "Company" or "Telo"), a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications in oncology, is thrilled t...